Rectal cancer: Dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression

Journal of Magnetic Resonance Imaging

Volumn 39, Issue 6, 2014, Pages 1436-1442

  Lollert, André ^a   Junginger, Theodor ^a   Schimanski, Carl Christoph ^a   Biesterfeld, Stefan ^b   Gockel, Ines ^a   Düber, Christoph ^a   Oberholzer, Katja ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

CXCR4; DCE MRI; EGFR; histopathology; immunohistochemistry; prognosis; rectal cancer; tumor microcirculation

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR; GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM; CXCR4 PROTEIN, HUMAN; GADOLINIUM PENTETATE;

AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; SCORING SYSTEM; ADENOCARCINOMA; DIAGNOSTIC USE; FOLLOW UP; IMAGE ENHANCEMENT; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OBSERVER VARIATION; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RECTUM TUMOR; VASCULARIZATION;

ADENOCARCINOMA; AGED; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; NEOVASCULARIZATION, PATHOLOGIC; OBSERVER VARIATION; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CXCR4; RECTAL NEOPLASMS;

EID: 84900028289     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24301     Document Type: Article

References (27)

1. Padhani AR,. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002; 16: 407-422.
2. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ,. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15: 621-628.
3. Hoffmann U, Brix G, Knopp MV, Heβ T, Lorenz WJ,. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995; 33: 506-514.
4. Kiessling F, Jugold M, Woenne EC, Brix G,. Non-invasive assessment of vessel morphology in tumors by magnetic resonance imaging. Eur Radiol 2007; 17: 2136-2148.
5. Fusco R, Sansone M, Maffei S, Raiano N, Petrillo A,. Dynamic contrast-enhanced MRI in breast cancer: a comparison between distributed and compartmental tracer kinetic models. J Biomed Graph Comput 2012; 2: 23-36.
6. Zwick S, Brix G, Tofts PS, et al. Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. Eur Radiol 2010; 20: 432-442.
7. Ono M, Kuwano M,. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res 2006; 12: 7242-7251.
8. Linggi B, Carpenter G,. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 2006; 16: 649-656.
9. Schimanski CC, Galle PR, Moehler M,. Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors. World J Gastroenterol 2008; 14: 4721-4724.
10. Fulton AM, the chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 2009; 11: 125-131.
11. Heald RJ, Ryall RD,. Recurrence and survival after total mesorectal resection for rectal cancer. Lancet 1986; 1: 1479-1482.
12. Thévenaz P, Ruttimann UE, Unser M,. A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process 1998; 7: 27-41.
13. Oberholzer K, Pohlmann A, Schreiber W, et al. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging 2008; 27: 1296-1301.
14. Wittekind C, Meyer HJ, Bootz F,. TNM-Klassifikation maligner Tumoren. 7th edition. New York: Springer; 2010. p 94-99.
15. Quirke P, Durdey P, Dixon MF, Williams NS,. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-999.
16. Schimanski CC, Schwald S, Simiantonaki N, et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 2005; 11: 1743-1750.
17. Hermanek P, Junginger T, Hossfeld DK, et al. Nachsorge und Rehabilitation bei Patienten mit gastrointerstinalen Tumoren. Dtsch Arzteblatt 1999; 96A: 2084-2088.
18. Schmiegel W, Pox C, Reinacher-Schick A, et al. S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol 2010; 48: 65-136.
19. Folkman J,. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
20. Griebel J, Mayr NA, de Vries A, et al. Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging 1997; 7: 111-119.
21. Hanahan D, Weinberg RA, the hallmarks of cancer. Cell 2000; 100: 57-70.
22. Christofori G, Semb H, the role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24: 73-76.
23. Herzig M, Savarese F, Novatchkova M, Semb H, Christofori G,. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene 2007; 26: 2290-2298.
24. Fidler IJ, Ellis LM, the implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-188.
25. Tuncbilek N, Karakas HM, Altaner S,. Dynamic MRI in indirect estimation of microvessel density, histologic grade, and prognosis in colorectal adenocarcinomas. Abdom Imaging 2004; 29: 166-172.
26. Zhang XM, Yu D, Zhang HL, et al. 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis. J Magn Reson Imaging 2008; 27: 1309-1316.
27. Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002; 54: 759-767.